Fear of COVID-19 & QOL in Patients With MS
The COVID-19 pandemic has proven to be especially traumatic for the elderly and those with chronic...
Read MoreJan 24, 2022
The COVID-19 pandemic has proven to be especially traumatic for the elderly and those with chronic...
Read MoreJan 20, 2022
While most of us are now used to wearing face masks and social distancing, life during the...
Read MoreJan 20, 2022
Women with advanced/recurrent endometrial cancer, especially those with the non-endometrioid (type...
Read MoreJan 19, 2022
Pulmonary medicine consultation during hospital admission may impact management of critical asthma...
Read MoreJan 18, 2022
In children with severe asthma (SA), targeting small airways with high-dose inhaled...
Read MoreJan 18, 2022
During the past several weeks, the news about the US healthcare system has been dire. ICUs are at...
Read MoreJan 18, 2022
Contributor Elaine C. Siegfried, MD, Professor of Pediatrics and Dermatology, Saint Louis...
Read MoreJan 14, 2022
Foster score, a self-reported inhaled corticosteroid adherence score for patients with asthma,...
Read MoreJan 12, 2022
With some exceptions, people with asthma are not at a higher risk for more severe disease,...
Read MoreJan 11, 2022
Ibrutinib was associated with prolonged progression-free survival (PFS) compared to the chemoimmunotherapy regimen bendamustine plus rituximab in older patients with treatment-naïve chronic lymphocytic leukemia (CLL). In...
Read MoreJan 11, 2022
Eradicating Helicobacter pylori bacterium increases the morbidities of asthma and other allergic...
Read MoreJan 10, 2022
According to published data, patients with mantle cell lymphoma (MCL), Waldenström macroglobulinemia (WM), marginal zone lymphoma (MZL), and chronic lymphocytic leukemia (CLL) experience frequent relapses over the course of...
Read MoreJan 10, 2022
The establishment of ibrutinib as a preferred first-line treatment option makes it important to understand the treatment sequence following first-line ibrutinib and the patient characteristics of those treated with a second-line...
Read MoreJan 10, 2022
Currently, the effect of the diagnosis-to-treatment interval (DTI) on survival in patients with mantle cell lymphoma (MCL) has not been extensively examined. Researchers aimed to determine the feasibility of active surveillance...
Read MoreJan 8, 2022
The combination of fludarabine, cyclophosphamide, and rituximab (FCR) is the only regimen other than allotransplantation shown in studies to result in a significant chance of functional cure in very long-term follow-up for...
Read MoreJan 5, 2022
The considerable commonalities between patients with obesity and Type 2 diabetes can be useful for...
Read MoreJan 4, 2022
A friend told me that he reduces the taxation of his solo internal medicine practice by paying...
Read MoreDec 21, 2021
Physician’s Weekly recently spoke with Matthias B. Bowman, MBA, of The Bowman Family Foundation, a private nonprofit organization with a primary mission of improving the lives of people with mental illness and providing funding...
Read MoreDec 17, 2021
As tears silently rolled down my patient’s face, I could feel my own eyes grow moist. Holding back...
Read More